m
Recent Posts
Connect with:
Tuesday / November 17.
Homeminews (Page 762)

New data from the five-year HORIZON pivotal trial shows that the Hydrus Microstent (Ivantis) lowers the rate of visual field loss in glaucoma patients

Johnson & Johnson has announced its intention to separate its consumer health business from its pharmaceutical and medical device business, in doing so creating

Optometrists from Australia and New Zealand gathered online in October to attend World Sight Day 2021: #LoveYourEyes, a virtual event presented by Johnson &

The Indigenous Diabetes Eyes and Screening (IDEAS) Van, which acts as Australia’s first mobile ophthalmic treatment facility operating to combat avoidable blindness in remote

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.